TY - JOUR
T1 - Intra-promoter switch of transcription initiation sites in proliferation signaling-dependent RNA metabolism
AU - Wragg, Joseph W
AU - White, Paige-Louise
AU - Hadzhiev, Yavor
AU - Wanigasooriya, Kasun
AU - Stodolna, Agata
AU - Tee, Louise
AU - Barros-Silva, Joao D
AU - Beggs, Andrew D
AU - Müller, Ferenc
N1 - Acknowledgements:
We thank The Human Biomaterials Resource Centre (BioBank), Birmingham, for fresh tissue samples and anonymized clinical data. We thank Genomics Birmingham for sequencing. This work was supported by the Wellcome Trust Investigator Award (106955) to F.M., Cancer Research UK, Advanced Clinician Scientist Award (ref. C31641/A23923) to A.B. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We would also like to thank C. Nepal and B. Lenhard for their comments on the manuscript.
Copyright:
© 2023. The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Global changes in transcriptional regulation and RNA metabolism are crucial features of cancer development. However, little is known about the role of the core promoter in defining transcript identity and post-transcriptional fates, a potentially crucial layer of transcriptional regulation in cancer. In this study, we use CAGE-seq analysis to uncover widespread use of dual-initiation promoters in which non-canonical, first-base-cytosine (C) transcription initiation occurs alongside first-base-purine initiation across 59 human cancers and healthy tissues. C-initiation is often followed by a 5' terminal oligopyrimidine (5'TOP) sequence, dramatically increasing the range of genes potentially subjected to 5'TOP-associated post-transcriptional regulation. We show selective, dynamic switching between purine and C-initiation site usage, indicating transcription initiation-level regulation in cancers. We additionally detail global metabolic changes in C-initiation transcripts that mark differentiation status, proliferative capacity, radiosensitivity, and response to irradiation and to PI3K-Akt-mTOR and DNA damage pathway-targeted radiosensitization therapies in colorectal cancer organoids and cancer cell lines and tissues.
AB - Global changes in transcriptional regulation and RNA metabolism are crucial features of cancer development. However, little is known about the role of the core promoter in defining transcript identity and post-transcriptional fates, a potentially crucial layer of transcriptional regulation in cancer. In this study, we use CAGE-seq analysis to uncover widespread use of dual-initiation promoters in which non-canonical, first-base-cytosine (C) transcription initiation occurs alongside first-base-purine initiation across 59 human cancers and healthy tissues. C-initiation is often followed by a 5' terminal oligopyrimidine (5'TOP) sequence, dramatically increasing the range of genes potentially subjected to 5'TOP-associated post-transcriptional regulation. We show selective, dynamic switching between purine and C-initiation site usage, indicating transcription initiation-level regulation in cancers. We additionally detail global metabolic changes in C-initiation transcripts that mark differentiation status, proliferative capacity, radiosensitivity, and response to irradiation and to PI3K-Akt-mTOR and DNA damage pathway-targeted radiosensitization therapies in colorectal cancer organoids and cancer cell lines and tissues.
U2 - 10.1038/s41594-023-01156-8
DO - 10.1038/s41594-023-01156-8
M3 - Article
C2 - 37996663
SN - 1545-9993
VL - 30
SP - 1970
EP - 1984
JO - Nature Structural and Molecular Biology
JF - Nature Structural and Molecular Biology
IS - 12
ER -